SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Green, A.R.
Right arrow Articles by Cross, A.J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Green, A.R.
Right arrow Articles by Cross, A.J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Studies on the enhancement of 5-hydroxytryptamine-mediated behaviour by chlormethiazole and phenytoin

A.R. Green

Astra Neuroscience Research Unit, 1 Wakefield Street, London WCIN 1PJ, UK

R.J. De Souza

Astra Neuroscience Research Unit, 1 Wakefield Street, London WCIN 1PJ, UK

A.J. Cross

Astra Neuroscience Research Unit, 1 Wakefield Street, London WCIN 1PJ, UK

Pre-treatment of rats with chlormethiazole (35 mg/kg) or diphenylhydantoin (phenytoin: 40 mg/kg) markedly enhanced the behavioural syndrome which is induced by injection of tranylcypromine (10 mg/kg) followed by L-tryptophan (50 mg/kg). Phenobarbitone (35 mg/kg) pre-treatment was without effect on the syndrome. This enhancement apparently involved a pre-synaptic mechanism since pre-treatment with chlormethiazole or phenytoin did not result in enhancement of the behavioural syndrome when it was induced by injection of the 5-HT1A agonist 8-OH-DPAT (0.75 mg/kg). Pre-treatment of rats with chlormethiazole did not alter the rate of 5-HT synthesis as measured by the accumulation of 5-HT following tranylcypromine. The K+-evoked release of endogenous 5-HT from brain slices was unaltered by addition of chlormethiazole (100 µM) to the medium while addition of phenytoin (100 µM) caused a small decrease. Administration of chlormethiazole or phenytoin failed to alter either the 5-HT2 receptor-mediated head twitch behaviour in mice induced by 5-hydroxytryptophan or the hypothermic response induced in mice by injection of 8-OH-DPAT (0.5 mg/kg s.c.). These data extend the original observation of enhancement of the 5-HT1A receptor-mediated behavioural syndrome by phenytoin, using a lower dose of the drug, and show that chlormethiazole has a similar effect, apparently through a pre synaptic mechanism. Some similarities to the effect of administration of Ca2+ antagonists and lithium are noted but no clear mechanism involving changes in ion flux have been identified to explain the mechanisms involved.

Key Words: 5-hydroxytryptamine-mediated behaviour • hypothermia • 5-hydroxytryptamine release; chlormethiazole • phenytoin • phenobarbitone

Journal of Psychopharmacology, Vol. 6, No. 3, 370-375 (1992)
DOI: 10.1177/026988119200600305


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement